Oxiconazole

Products Oxiconazole was commercially available in the form of vaginal tablets (Oceral). It was approved in many countries since 1983. It was discontinued in 2017. Structure and properties Oxiconazole (C18H13Cl4N3O, Mr = 429.1 g/mol) is present in drugs as oxiconazole nitrate. It is an imidazole derivative. Effects Oxiconazole (ATC D01AC11, ATC G01AF17) has antifungal properties … Oxiconazole

Axitinib

Products Axitinib was approved in many countries in 2012 in film-coated tablet form (Inlyta). Structure and properties Axitinib (C22H18N4OS, Mr = 386.5 g/mol) is a benzamide and benzindazole derivative. It exists as a white to slightly yellow powder. Effects Axitinib (ATC L01XE17) has antitumor properties. The effects are due to inhibition of VEGFR-1, -2, and … Axitinib

Mercury

Application Mercury (Hydrargyrum, Hg) and its compounds are rarely used in pharmacy today because of their toxicity and adverse effects. An exception is alternative medicine, in which mercury is also called mercurius (e.g., Mercurius solubilis, Mercurius vivus). The English name is Mercury or Quicksilver. In the 20th century, mercury compounds were still widely used and … Mercury

Quetiapine

Products Quetiapine is commercially available in the form of film-coated tablets and sustained-release tablets (Seroquel / XR, generic, auto-generic). It has been approved in many countries since 1999. Generics of film-coated tablets entered the market in 2012, and generics of sustained-release tablets were first registered in 2013. Structure and properties Quetiapine (C21H25N3O2S, Mr = 383.5 … Quetiapine

Minocycline

Products Minocycline is commercially available in the form of film-coated tablets (Minocin). It has been approved in many countries since 1984. Minac capsules are out of commerce. Topical medicines are additionally available in some countries. Structure and properties Minocylcine (C23H27N3O7, Mr = 457.5 g/mol) is present in drugs as minocycline hydrochloride, a yellow, crystalline, hygroscopic … Minocycline

Aceclofenac

Products Aceclofenac is approved in Germany, among other countries, in the form of film-coated tablets (Beofenac). It is not registered in many countries. Structure and properties Aceclofenac (C16H13Cl2NO4, Mr = 354.2 g/mol) is structurally related to diclofenac and is partially metabolized to it. It exists as a white crystalline powder that is practically insoluble in … Aceclofenac

Acarbose Effects and Side Effects

Products Acarbose is commercially available in tablet form (Glucobay). It is usually combined with other agents such as metformin, insulin, or sulfonylureas to enhance the antidiabetic effect. Acarbose has been approved in many countries since 1986. Structure and properties Acarbose (C25H43NO18, Mr = 645.60 g/mol) is a pseudotetrasaccharide obtained from the bacterium by fermentation. It … Acarbose Effects and Side Effects

Bisphosphonates Effects and Side Effects

Products Bisphosphonates are commercially available in the form of film-coated tablets and as injection and infusion preparations. They are also combined fixed with vitamin D3. Their effects on bone were described in the 1960s. Etidronate was the first active ingredient to be approved (out of trade). Structure and properties Bisphosphonates contain a central carbon atom … Bisphosphonates Effects and Side Effects

5-Aminolevulinic Acid

Products Aminolevulinic acid is commercially available as patches and gels (Alacare, Ameluz). Structure and properties The 5-aminolevulinic acid (C5H9NO3, Mr = 131.1 g/mol) is a nonproteinogenic amino acid. It exists in the drug as a hydrochloride, a white crystalline solid that is soluble in water. Effects 5-Aminolevulinic acid (ATC L01XD04) is phototoxic and causes destruction … 5-Aminolevulinic Acid

Benserazide

Products Benserazide is commercially available in fixed combination with levodopa in tablet and capsule form (Madopar). It has been approved in many countries since 1973. Structure and properties Benserazide (C10H15N3O5, Mr = 257.2 g/mol) is a racemate. It exists as benserazide hydrochloride, a white to yellowish-white or orange-white crystalline powder that is readily soluble in … Benserazide

Benzbromarone

Products Benzbromarone was withdrawn from the market in many countries in 2003 because of its hepatotoxicity. Desuric and other drugs are no longer available. It is still available in other countries. The withdrawal was not without controversy (Jansen, 2004). Structure and properties Benzobromarone (C17H12Br2O3, Mr = 424.1 g/mol) is a derivative of khellin. It exists … Benzbromarone